OnKure Therapeutics, Inc. (OKUR) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Patients Dosed in Fulvestrant Combination Arm (PIKture-01) | 33.00 | FY2025-Q4 |
| Patients Dosed in Monotherapy Arm (PIKture-01) | 38.00 | FY2025-Q4 |
| Total Patients Dosed Across Monotherapy and Fulvestrant Combination Arms | 71.00 | FY2025-Q4 |
Back to OKUR overview · OKUR earnings · OKUR holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.